March 28, 2024
Recent challenges of the 340B Drug Discount Program were a focal point of a March 26, 2024 article in Law360. The publication also highlighted the recent arrival of Feldesman Partner Steve Kuperberg [...]
March 21, 2024
Washington, DC – Feldesman Leifer LLP (Feldesman) proudly welcomes Stephen Kuperberg as a Partner in the firm’s Health Care and Litigation & Government Investigations Practice Groups effective March 18, 2024. With over [...]
May 18, 2023
The Health Subcommittee of the House of Representatives’ Energy and Commerce Committee held a markup hearing on May 17, 2023 to discuss a series of bills relating to transparency and competition in [...]
May 4, 2023
Next week, FTLF partners Jaqueline “Jacki” Leifer, Dianne K. Pledgie, Jason B. Reddish and Carrie Riley will speak on current compliance and 340B Program challenges at the Massachusetts League of Community Health [...]
March 2, 2023
Next week, FTLF attorneys Martin Bree, Molly Evans, Matt Freedus, Susannah Vance Gopalan, Jason Reddish and Ted Waters will speak at the National Association of Community Health Centers’ (NACHC) Policy & Issues [...]
February 1, 2023
The United States Court of Appeals for the Third Circuit ruled on Monday in favor of drug manufacturers AstraZeneca, Sanofi and Novo Nordisk in their challenge against attempts by the Health Resources [...]
June 16, 2022
On June 15, 2022, the United States Supreme Court issued a unanimous ruling (“Decision”) handing a substantial win to hospitals participating in the 340B program. In 2018, the Centers for Medicare and [...]
January 26, 2022
FTLF’s 340B/Pharmacy Partners Michael B. Glomb and Jason B. Reddish will speak at the Annual 2022 340B Coalition Winter Conference next week in San Diego, CA. During the three-day conference, FTLF Partners will participate in the following sessions: [...]
December 10, 2020
On December 10, 2020, the Supreme Court ruled in a unanimous decision (8-0) in Rutledge v. Pharmaceutical Care Management Association (PCMA)[1] that an Arkansas law that requires Pharmacy Benefit Managers (PBMs) to [...]
April 6, 2020
HRSA’s Office of Pharmacy Affairs (OPA) has posted guidance for 340B covered entities during the COVID-19 pandemic. The guidance can be accessed on the HRSA OPA website at https://www.hrsa.gov/opa/COVID-19-resources. Some of the [...]